⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL7901678 | 0.86 | FNTA (0.58) | — | |
| SCHEMBL5358862 | 0.83 | ALDH1A1 (0.37) | — | |
| SCHEMBL2767610 | 0.79 | ESR1 (0.72) | — | |
| SCHEMBL7548532 | 0.77 | ESR1 (0.68) | — | |
| SCHEMBL1270113 | 0.77 | ESR1 (0.68) | — | |
| SCHEMBL2724941 | 0.75 | — | — | |
| SCHEMBL7670922 | 0.75 | TSHR (0.50) | — | |
| SCHEMBL3083359 | 0.75 | CYP1A2 (0.50) | — | |
| SCHEMBL3873458 | 0.73 | ESR1 (1.00) | — | |
| SCHEMBL2969737 | 0.73 | ESR1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7001887-B2 | Blood coagulation factor VIIa inhibitors | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-02-21 | — | — | US | claimed |
| US-20040087511-A1 | Peptide derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2004-05-06 | — | — | US | claimed |
| EP-1364960-A1 | PEPTIDE DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-11-26 | — | — | EP | claimed |
| EP-0870088-A1 | PROCESS FOR PREPARING A LIGNOCELLULOSE-BASED PRODUCT, AND PRODUCT OBTAINABLE BY THE PROCESS | NOVO NORDISK A/S (DK) | 1998-10-14 | — | — | EP | claimed |
| WO-1997017492-A1 | PROCESS FOR PREPARING A LIGNOCELLULOSE-BASED PRODUCT, AND PRODUCT OBTAINABLE BY THE PROCESS | NOVO NORDISK A/S (DK) | 1997-05-15 | — | — | WO | claimed |
| CN-116075368-B | Resin composition, cured product, method for producing same, and laminate | 三菱化学株式会社 | 2024-06-11 | — | — | CN | disclosed |
| WO-2024075075-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | RENEXXION IRELAND LIMITED (IE) | 2024-04-11 | — | — | WO | disclosed |
| CN-116075368-A | Resin composition, cured product, method for producing same, and laminate | 三菱化学株式会社 | 2023-05-05 | — | — | CN | disclosed |
| CN-107918247-B | Colored curable resin composition | 住友化学株式会社 | 2022-03-18 | — | — | CN | disclosed |
| CN-106019840-B | Colored curable resin composition | 东友精细化工有限公司 | 2021-01-29 | — | — | CN | disclosed |
| WO-2020154917-A1 | PHOSPHATE AND PHOSPHONATE BASED COMPOUNDS OF 6-THIO-2'-DEOXYGUANOSINE AS ANTI-CANCER AGENTS | MINGHUI PHARMACEUTICAL (SHANGHAI) LIMITED (CN) | 2020-08-06 | — | — | WO | disclosed |
| CN-104298073-B | Colored curable resin composition | 东友精细化工有限公司 | 2019-11-29 | — | — | CN | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| US-4742073-A | ANTIGLAUCOMA | BUNDGAARD HANS (DK) | 1988-05-03 | — | — | US | disclosed |
| US-4701452-A | STIMULANTS; ANTIBIOTICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-10-20 | — | — | US | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
| EP-0152860-A2 | Use of cephalosporin compounds for the manufacture of a medicament for the modulation of the immunologic system | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-08-28 | — | — | EP | disclosed |
| US-4454129-A | ANTIBIOTICS, BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-06-12 | — | — | US | disclosed |
| EP-0106541-A2 | Pilocarpine prodrugs | Bundgaard, Hans (DK) | 1984-04-25 | — | — | EP | disclosed |
| EP-0064256-A2 | Cephalosporin derivatives and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-11-10 | — | — | EP | disclosed |